Atea Pharmaceuticals Stock Shows Resilience Amid Volatility Following Phase 2 Study Results
Atea Pharmaceuticals’ stock price has shown resilience, recovering from a 52-week low of $2.60 to close at $2.72 on May 8, 2025, amidst notable volatility in the past year.
2 minutes to read